ABUS

Arbutus Biopharma
$4.41
+$0.03 (+0.68%)Jul 27, 2026
8.5GreatMoatMint rating

MoatMint rates Arbutus Biopharma (ABUS) 8.5 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 4.9 out of 10.

Key metrics

The numbers that frame ABUS today
Market cap
$871.14M
P/E (TTM)
5.4
EV / FCF
-25.0
Gross margin
100%
EV / Sales
4.4
ROIC
137.6%
Div yield
0%
Debt / equity
0.0
52wk Low
$3.20
52wk High
$5.38

ABUS stock rating

How ABUS scores on quality, value, growth, momentum and financial health
8.5out of 10
Great overallHealthy business, fair priceTop 15% of ~5,000 US stocks
QualityNeutral4.9/10
GrowthGreat9.8/10
MomentumGood6.7/10
ValueGood6.4/10
Financial HealthGreat9.5/10

Growth

Revenue and earnings trend for ABUS
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about ABUS
Is Arbutus Biopharma a good buy?
Hold. Arbutus Biopharma has mixed quality and strong momentum. The setup is mixed. Growth looks excellent, which supports the long-term business case. We think Arbutus Biopharma is selling at a fair price.
What is the market capitalization of ABUS?
Arbutus Biopharma's market capitalization is $871.14M.
What is the P/E ratio for ABUS stock?
Arbutus Biopharma's current P/E ratio is 5.4.
What is the 52-week high for ABUS stock?
The 52-week high for Arbutus Biopharma is $5.38. The current close of $4.41 is 18% below that high.
What is the 52-week low for ABUS stock?
The 52-week low for Arbutus Biopharma is $3.20. The current close of $4.41 is 38% above that low.
Does ABUS stock pay dividends?
Arbutus Biopharma does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ABUS?
Arbutus Biopharma's Debt / Equity ratio is 0.02.